Screener/Healthcare/Biotechnology

ALNY

Alnylam Pharmaceuticals, Inc.NASDAQ
$307.73+1.10 (+0.36%)
Nasdaq 100Large CapHealthcareFastest GrowingHigh ROELow Beta
$205.87
$495.55
$299.62
$308.91
EPS (TTM)$2.01
P/E Ratio153.10
Dividend Yield—
Market Cap$41.40B
Volume1.08M
Prev Close$306.66
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$1.1B$111.5M$0.8275.6%10.2%
Q3 '25$1.2B$251.1M$1.8484.2%20.1%
Q2 '25$773.7M-$66.3M$-0.5181.6%-8.6%
Q1 '25$594.2M-$18.3M$-0.1488.2%-3.1%
Q4 '24$593.2M-$83.8M$-0.6582.7%-14.1%
Q3 '24$500.9M-$111.6M$-0.8783.6%-22.3%
Q2 '24$659.8M-$16.9M$-0.1389.8%-2.6%
Q1 '24$494.3M-$65.9M$-0.5289.0%-13.3%
Get Your Daily Market Recap